UBS’s Rockwell Medical RMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$22K Sell
22
-7
-24% -$7.91K ﹤0.01% 7899
2014
Q2
$38K Buy
29
+5
+21% +$6.01K ﹤0.01% 7244
2014
Q1
$33K Sell
24
-13
-35% -$16.9K ﹤0.01% 7398
2013
Q4
$43K Sell
37
-298
-89% -$411K ﹤0.01% 7155
2013
Q3
$421K Buy
335
+120
+56% +$81.5K ﹤0.01% 4331
2013
Q2
$85K Buy
+215
New +$91.1K ﹤0.01% 6093

Other funds holding RMTI

UBS's RMTI Position: Q3 2014 in Review

UBS increased its Rockwell Medical (RMTI) stake by 1.8% in Q3 2014, buying an estimated $9.04K and bringing the position to 458 shares worth $461K. The position accounts for ﹤0.01% of the portfolio, ranked #4360.

UBS first reported a position in RMTI in Q2 2013 and has held it in 6 quarters since. The position peaked at $923K in Q1 2014. 82 funds tracked by Wall St. Rank hold RMTI as of Q3 2014.

  • UBS held 458 shares of Rockwell Medical worth $461K as of Q3 2014.
  • UBS bought 8 Rockwell Medical shares in Q3 2014, an estimated $9.04K.
  • Rockwell Medical made up ﹤0.01% of UBS's portfolio in Q3 2014, its #4360 holding.
  • UBS first reported a position in Rockwell Medical in Q2 2013 and has held it in 6 quarters since.
  • UBS's Rockwell Medical position peaked at $923K in Q1 2014.
  • 82 funds tracked by Wall St. Rank held Rockwell Medical as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.